Archived Insight | May 24, 2019

Medicare Part D Drug Benefit Program Changes for 2020

The Medicare Part D standard benefit design parameters will be higher in 2020, the Centers for Medicare & Medicaid Services (CMS) recently announced.

While the deductible will increase by less than 5 percent, the out-of-pocket threshold will increase dramatically: 24 percent.

The reason for the jump in the out-of-pocket threshold, sometimes known as the TrOOP, is the expiration of a provision of the Affordable Care Act (ACA) that slowed the growth of the TrOOP between 2014 and 2019.

In 2020 and beyond, the TrOOP will be determined using a pre-ACA calculation. Plan sponsors that contract with a Medicare Part D Prescription Drug Plan or Medicare Advantage-Prescription Drug Plan (also known as EGWPs) will likely receive lower payments from CMS as a result of this change, meaning that these plans will be more expensive.

CMS also announced that the Retiree Drug Subsidy (RDS) amounts it pays to sponsors of group health plans that provide prescription drug coverage to Medicare-eligible retirees will be higher in 2020. 

2020 Medicare Part D changes Download Now

Question about this update?

Get in touch. 

Speak with Us

See more insights

Asian Father And Son Playing With Building Blocks At Home

Proposed Rules for Employer Contributions to Trump Accounts

Learn how proposed Trump Account rules could affect employer contributions, cafeteria plans and nondiscrimination testing.
African Young Man Working On Digital Tablet At Coffee Shop

Expanded Electronic Delivery Proposed for Group Health Plans

Learn how the DOL's proposed electronic disclosure safe harbor could affect group health plan communications and compliance.
Female Pharmacist Explaining A Medication And Prescribing Medication To A Customer In The Pharmacy

Medicare Part D Demonstration Program Will End on 12/31/26

Learn what the early end of the Medicare Part D Demonstration program means for premiums and retiree health plans.

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.